Sartorius first-quarter earnings substantially improved over the year-earlier quarter
In fiscal 2004, first-quarter sales revenue for the Sartorius Group rose 1.0% to EUR108.1 million from EUR107.0 million reported for the year-earlier period. Currency-adjusted consolidated sales revenue grew 5.4% to EUR112.8 million. The Biotechnology Division posted sales revenue growth of 3.5% to EUR54.6 million (year-earlier period: EUR52.8 million; currency-adjusted, 8.2%). First-quarter sales revenue for the Mechatronics Division slid 1.3% to EUR53.5 million (previous year: EUR54.2 million; currency-adjusted, +2.7%).
Concerning order intake, the Sartorius Group posted a first-quarter decline of 1.7% to EUR113.4 million from EUR115.4 million a year earlier, which was due to the impact of foreign exchange rates (currency-adjusted order intake: +4.9%). For the Biotechnology Division, order intake fell from EUR59.9 million to EUR54.9 million (-8.4%). Order intake for the Mechatronics Division rose 5.5% to EUR58.6 million (previous year: EUR55.5 million).
Net cash flow at EUR4.1 million continues to be positive (previous year: EUR6.9 million). In the period ended March 31, 2004, net debt shrank by EUR2.7 million to EUR102.3 million compared with the period ended December 31, 2003.
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.